DetermInants of Antimicrobial Use aNd De-escalAtion in Critical Care (DIANA)
NCT02920463 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1495
Last updated 2019-09-20
Summary
DetermInants of Antimicrobial use aNd de-escalAtion in critical care (DIANA study), is a multicenter, international, prospective, observational cohort study, aiming to describe the rate of de-escalation as well as the associated outcome and the empirical antibiotic therapy for infections at the intensive care unit.
Conditions
Sponsors & Collaborators
-
University Hospital, Ghent
lead OTHER
Principal Investigators
-
Jan J De Waele, MD,PhD · University Hospital, Ghent
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-10-01
- Primary Completion
- 2018-06-30
- Completion
- 2018-06-30
Countries
- Belgium
Study Locations
More Related Trials
-
Neurotoxicity Evaluation of Beta-lactams in Intensive Care Unit and Identification of the Risk Factors
NCT03628300 ·Status: COMPLETED
-
Impact of 30 mg/kg Amikacin and 8 mg/kg Gentamicin on Serum Concentrations in Critically Ill Patients With Severe Sepsis
NCT02898961 ·Status: COMPLETED ·Phase: PHASE4
-
Extracorporeal Therapy and Therapeutic Drug Monitoring
NCT07287813 ·Status: NOT_YET_RECRUITING
-
Dendritic Cells-Derived Exosomes in Human Sepsis
NCT02957279 ·Status: UNKNOWN
-
Therapeutic Monitoring of Antibiotics in Intensive Care Patients: a Cohort Study PopTDM-ICU
NCT05367011 ·Status: NOT_YET_RECRUITING
-
Studies of Blood DNA in Patients With Severe Infection DYNAMICS
NCT01355042 ·Status: COMPLETED
-
Pharmacokinetic/Pharmacodynamic Evaluation Amikacin in Critically Ill Patients Admitted at the Emergency Department
NCT02365272 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of Dexmedetomidine on Respiratory Function and Inflammatory Responses in Patient With Sepsis Undergoing Cleaning Focus of Infection
NCT02842437 ·Status: UNKNOWN ·Phase: NA
-
Empiric Antibiotic Treatment for Septic Patients in the Intensive Care Unit
NCT05924126 ·Status: RECRUITING
-
Quantification of Bacterial DNA in Sepsis
NCT03782454 ·Status: UNKNOWN
-
Sepsis in the ICU-II
NCT04695119 ·Status: ACTIVE_NOT_RECRUITING
-
Epidemiology of Bacteremia at Two Tertiary ICUs in Switzerland
NCT05236283 ·Status: COMPLETED
-
Beta-lactam Intermittent Versus Continuous Infusion and Combination Antibiotic Therapy in Sepsis
NCT05681442 ·Status: RECRUITING ·Phase: PHASE4
-
Procalcitonin Monitoring May Decrease Antibiotic Use in the Intensive Care Unit
NCT01085994 ·Status: UNKNOWN
-
Procalcitonin to Shorten Antibiotics Duration in ICU Patients
NCT01379547 ·Status: UNKNOWN ·Phase: PHASE3
-
Integrated Clinical Decision Support for Empiric Antibiotic Selection in Sepsis
NCT06103500 ·Status: RECRUITING ·Phase: NA
-
Beta-Lactam Antibiotics InitiaL ExpoSure OptimisEd in CriticallY Ill Patients with SEpsis
NCT06766461 ·Status: RECRUITING ·Phase: PHASE4
-
Antibiotics Management of Septic Neutropenic Patients in the Intensive Care Unit
NCT03217721 ·Status: COMPLETED
-
The Diagnostic and Prognostic Value of Presepsin in Sepsis
NCT06180265 ·Status: COMPLETED ·Phase: NA
-
Bacterial Infection Diagnosis Using Blood DNA
NCT00698919 ·Status: UNKNOWN
-
PK/PD Study of Anti-Infective Drugs in Critically Ill Patients Receiving Extracorporeal Membrane Oxygenation Treatment
NCT06319677 ·Status: NOT_YET_RECRUITING
-
Next-Generation Sequencing Diagnostics of Bacteremia in Sepsis
NCT03356249 ·Status: COMPLETED
-
Efficacy of Anisodamine Hydrobromide Combined With Low-molecular-weight Heparin in the Treatment of Patients With Sepsis
NCT05634057 ·Status: RECRUITING ·Phase: NA
-
Pharmacokinetic of Ceftriaxone in Septic ICU Patients
NCT00449800 ·Status: UNKNOWN ·Phase: PHASE4
-
Prolonged Intravenous Infusion of β-lactam Antibiotics in Early Septic Patients
NCT05024565 ·Status: UNKNOWN ·Phase: NA